Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by P. Ost
Radioterapia pélvica electiva en el cáncer de próstata: el ocaso de una práctica histórica
Ayuda Buscar en la ayuda Buscar en la ayuda Radioterapia pélvica electiva en el cáncer de próstata: el ocaso de una práctica histórica A. Ocanto [1] ; F. López Campos [2] ; P. Ost [3] ; F.
ITGB1 serves as a therapeutic target for reducing lung cancer bone metastasis
Shasha Jiang is a doctor-postgraduate student in the Medical School of Chinese PLA, majoring in thoracic surgery. She received her Bachelor’s degree and Master’s degree at Army Medical University. She has been doing research on lung cancer for several years. Shilin Li is currently a postgraduate in the National Center for Nanoscience and Technology of China. He obtained his Bachelor's Degree from the college of life science, Northwest University.
Is There a Benefit of Combining Immunotherapy and Radiotherapy in Bladder Cancer?
Sharma P. Retz M. Siefker-Radtke A. Baron A. Necchi A. Bedke J. et al. Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2017; 18: 312-322 Bellmunt J. de Wit R. Vaughn D.J. Fradet Y. Lee J.L. Fong L. et al. Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med. 2017; 376: 1015-1026 Abuodeh Y. Venkat P. Kim S. Systematic review of case reports on the abscopal effect. Curr Probl Cancer.
Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences
To view the full text, please login as a subscribed user or purchase a subscription . Click here to view the full text on ScienceDirect. To report the relapse pattern of stereotactic body radiotherapy (SBRT) for oligorecurrent nodal prostate cancer (PCa). PCa patients with ≤3 lymph nodes (N1/M1a) at the time of recurrence were treated with SBRT. SBRT was defined as a radiotherapy dose of at least 5 Gy per fraction to a biological effective dose of at least 80 Gy to all metastatic sites.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with P.
Contact P., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack